Clinical Trial

Third Party Viral Specific T-cells (VSTs)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infections.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2015-08-21; most recent amendment 2025-12-10.
Status change: Not Yet Recruiting → Recruiting 2016-01-26
Trial Details
NCT Number NCT02532452
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Conditions Viral Infection, Viral Reactivation, Infection in an Immunocompromised Host
Enrollment 750 participants
Start Date 2015-09-02
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-16